JP2002530293A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002530293A5 JP2002530293A5 JP2000582535A JP2000582535A JP2002530293A5 JP 2002530293 A5 JP2002530293 A5 JP 2002530293A5 JP 2000582535 A JP2000582535 A JP 2000582535A JP 2000582535 A JP2000582535 A JP 2000582535A JP 2002530293 A5 JP2002530293 A5 JP 2002530293A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell
- composition according
- host
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004027 cell Anatomy 0.000 description 20
- 239000000203 mixture Substances 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 210000004698 lymphocyte Anatomy 0.000 description 8
- 201000010099 disease Diseases 0.000 description 5
- 208000035475 disorder Diseases 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 208000037357 HIV infectious disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9825096.2 | 1998-11-16 | ||
| GB9825096A GB2343679A (en) | 1998-11-16 | 1998-11-16 | Autologous transplantation and method for making cells dormant |
| PCT/GB1999/003813 WO2000029551A2 (en) | 1998-11-16 | 1999-11-16 | Cells, culture methods, and their use in autologous transplantation therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002530293A JP2002530293A (ja) | 2002-09-17 |
| JP2002530293A5 true JP2002530293A5 (OSRAM) | 2007-01-11 |
Family
ID=10842531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000582535A Pending JP2002530293A (ja) | 1998-11-16 | 1999-11-16 | 自己移植療法における細胞、培養方法およびその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20060246042A1 (OSRAM) |
| EP (1) | EP1131408B1 (OSRAM) |
| JP (1) | JP2002530293A (OSRAM) |
| AT (1) | ATE321843T1 (OSRAM) |
| AU (1) | AU775597B2 (OSRAM) |
| CY (1) | CY1105439T1 (OSRAM) |
| DE (1) | DE69930660T2 (OSRAM) |
| DK (1) | DK1131408T3 (OSRAM) |
| ES (1) | ES2262346T3 (OSRAM) |
| GB (1) | GB2343679A (OSRAM) |
| PT (1) | PT1131408E (OSRAM) |
| WO (1) | WO2000029551A2 (OSRAM) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0322806D0 (en) | 2003-09-30 | 2003-10-29 | Lifeforce Group Plc | Cell bank for contingent autologous leukocyte transplantation |
| EP1711214A1 (en) | 2004-02-02 | 2006-10-18 | Interface Multigrad Technology (IMT) Ltd. | Device for directional cooling of biological matter |
| JP4777908B2 (ja) | 2004-02-02 | 2011-09-21 | コア・ダイナミクス・リミテッド | 生物学的材料ならびに生物学的材料の保存のための方法および溶液 |
| ATE460947T1 (de) | 2004-06-07 | 2010-04-15 | Core Dynamics Ltd | Verfahren zur sterilisation von biologischen präparaten |
| US8037696B2 (en) | 2004-08-12 | 2011-10-18 | Core Dynamics Limited | Method and apparatus for freezing or thawing of a biological material |
| US8198085B2 (en) | 2005-08-03 | 2012-06-12 | Core Dynamics Limited | Somatic cells for use in cell therapy |
| DE102007004855B4 (de) * | 2007-01-31 | 2014-03-27 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Vorrichtung und Verfahren zur Deposition von biologischem Material in einem Zielsubstrat |
| US20120070450A1 (en) * | 2009-03-24 | 2012-03-22 | Riken | Leukemia stem cell markers |
| EP2943206A4 (en) * | 2013-01-12 | 2017-01-04 | Cesca Therapeutics Inc. | Rapid infusion of autologous bone marrow derived stem cells |
| ES2729640T3 (es) * | 2013-10-24 | 2019-11-05 | Neuroplast Beheer B V | Procedimiento de reducción de la actividad inflamatoria de un trasplante de células madre y usos del mismo |
| CN105219709A (zh) * | 2015-09-23 | 2016-01-06 | 上海吉泉生物技术有限公司 | 单采法建立免疫细胞库及应用 |
| CL2016000753A1 (es) * | 2016-03-31 | 2017-11-10 | Fund Ciencia Para La Vida | Atenuación de la neurodegeneración asociada a la enfermedad de parkison mediante la inhibición del receptor de dopamina d3 en células t cd4+. |
| JP6401818B2 (ja) * | 2016-04-27 | 2018-10-10 | 株式会社金太郎ＣｅｌｌｓＰｏｗｅｒ | 活性化幹細胞製造方法 |
| DE102021116694B4 (de) * | 2021-06-29 | 2023-03-09 | Promocell Gmbh | Wässrige Lösung zur Zellkonservierung |
| CN114984048A (zh) * | 2022-06-16 | 2022-09-02 | 浙江百越生物技术有限公司 | 一种预防与治疗老年人行动迟缓的细胞疗法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5004681B1 (en) * | 1987-11-12 | 2000-04-11 | Biocyte Corp | Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
| JPH04282301A (ja) * | 1991-03-08 | 1992-10-07 | Kachiku Jiyuseiran Ishiyoku Gijutsu Kenkyu Kumiai | 生物試料の急速凍結方法 |
| US5750376A (en) * | 1991-07-08 | 1998-05-12 | Neurospheres Holdings Ltd. | In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny |
| AU6167394A (en) * | 1993-01-27 | 1994-08-15 | Hemosol Inc. | Selective cell proliferation |
| AU8078894A (en) * | 1993-10-08 | 1995-05-04 | Cellpro Ii | Methods for collection and cryopreservation of human granulocytes |
| US5866332A (en) * | 1994-02-02 | 1999-02-02 | Incyte Pharmaceuticals, Inc. | Human myeloid terminal differentiation response gene |
| EP0668013B1 (en) * | 1994-02-22 | 2005-04-20 | Nippon Telegraph And Telephone Corporation | Freeze-dried blood cells, stem cells and platelets and manufacturing method for the same |
| US5704889A (en) * | 1995-04-14 | 1998-01-06 | Cobe Laboratories, Inc. | Spillover collection of sparse components such as mononuclear cells in a centrifuge apparatus |
| US5865784A (en) * | 1995-06-07 | 1999-02-02 | Alliance Pharmaceutical Corp. | Method of hemodilution facilitated by monitoring oxygenation status |
| US5922597A (en) * | 1995-11-14 | 1999-07-13 | Regents Of The University Of Minnesota | Ex vivo culture of stem cells |
| JP2002515756A (ja) * | 1997-01-31 | 2002-05-28 | ヘモソル インク． | 選択されたリンパ球の生産方法 |
| AU6346898A (en) * | 1997-03-06 | 1998-09-22 | University Of Massachusetts | Gene therapy using bone marrow transplants transfected with therapeutic genes under the control of tissue-specific promoters |
-
1998
- 1998-11-16 GB GB9825096A patent/GB2343679A/en not_active Withdrawn
-
1999
- 1999-11-16 WO PCT/GB1999/003813 patent/WO2000029551A2/en not_active Ceased
- 1999-11-16 JP JP2000582535A patent/JP2002530293A/ja active Pending
- 1999-11-16 AT AT99954269T patent/ATE321843T1/de not_active IP Right Cessation
- 1999-11-16 ES ES99954269T patent/ES2262346T3/es not_active Expired - Lifetime
- 1999-11-16 PT PT99954269T patent/PT1131408E/pt unknown
- 1999-11-16 AU AU10680/00A patent/AU775597B2/en not_active Ceased
- 1999-11-16 EP EP99954269A patent/EP1131408B1/en not_active Revoked
- 1999-11-16 DE DE69930660T patent/DE69930660T2/de not_active Expired - Lifetime
- 1999-11-16 DK DK99954269T patent/DK1131408T3/da active
-
2006
- 2006-04-10 US US11/400,767 patent/US20060246042A1/en not_active Abandoned
- 2006-06-26 CY CY20061100868T patent/CY1105439T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005001080A3 (en) | Postpartum-derived cells for use in treatment of disease of the heart and circulatory system | |
| DK1856272T3 (da) | Anvendelse af fremstillet produkt og fremgangsmåde til fremstilling af kollagenopløsning og fremgangsmåde til kollagenseparation af dyrevæv | |
| CN108721200A (zh) | 一种人间充质干细胞来源的外泌体美容制剂的制备方法及应用 | |
| JP2005500375A5 (OSRAM) | ||
| WO2002008389A3 (en) | Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue | |
| WO2003085092A3 (en) | Cellular transplantation for heart regeneration | |
| Canizo et al. | Peripheral endothelial progenitor cells (CD133+) for therapeutic vasculogenesis in a patient with critical limb ischemia. One year follow-up | |
| ATE300310T1 (de) | Verfahren zur steigerung von hematopoietischen zellen | |
| WO2006091895A3 (en) | Method for the treatment of retinopathy of prematurity and related retinopathic diseases | |
| Rahimpour et al. | γδ T cells augment rejection of skin grafts by enhancing cross-priming of CD8 T cells to skin-derived antigen | |
| WO2000029551B1 (en) | Cells, culture methods, and their use in autologous transplantation therapy | |
| Cassano et al. | Mesenchymal stem Cell therapy: Clinical progress and opportunities for advancement | |
| WO2003029432A3 (en) | Human mesenchymal progenitor cell | |
| Riddell et al. | Immunotherapy of human viral and malignant diseases with genetically modified T-cell clones. | |
| Imahara et al. | Skin grafts | |
| Saidi | Live skin allograft in the management of severe burns | |
| JP2002331025A5 (OSRAM) | ||
| Souza | Investigation of cytidine triphosphate synthase 1 inhibition in allogeneic transplantation mice models: acute graft-versus-host disease and skin graft rejection | |
| Wanders | Drug-modified rejection of rat cardiac allografts. | |
| Taner | of the Liver and Its Mesenchymal Stem | |
| JPS59162889A (ja) | 人の悪性腫瘍細胞の増殖抑制剤の製造方法 | |
| Borzenok et al. | MMSC-LIKE LIMBAL CELLS COTRANSPLANTATION PROMOTES LOCAL IMMUNOCORRECTION AND CORNEAL GRAFT TRANSPARENT RETENTION IN HIGH RISK KERATOPLASTY | |
| Dander et al. | Understanding the immunomodulatory effect of mesenchymal stem cell infused in transplanted patients with steroid-refractory GVHD | |
| Syrtseva | GENERATIONAL THEORY AS ONE OF THE BASIS FOR BRAND PORTFOLIO DIFFERENTIATION | |
| EP3560504A1 (en) | Cells differentiated from mesenchymal stem cells for the treatment of dermal lesions |